Mouse models of diabetic nephropathy.

Diabetic nephropathy is a major cause of ESRD worldwide. Despite its prevalence, a lack of reliable animal models that mimic human disease has delayed the identification of specific factors that cause or predict diabetic nephropathy. The Animal Models of Diabetic Complications Consortium (AMDCC) was created in 2001 by the National Institutes of Health to develop and characterize models of diabetic nephropathy and other complications. This interim report and our online supplement detail the progress made toward that goal, specifically in the development and testing of murine models. Updates are provided on validation criteria for early and advanced diabetic nephropathy, phenotyping methods, the effect of background strain on nephropathy, current best models of diabetic nephropathy, negative models, and views of future directions. AMDCC investigators and other investigators in the field have yet to validate a complete murine model of human diabetic kidney disease. Nonetheless, the critical analysis of existing murine models substantially enhances our understanding of this disease process.

[1]  C. Alpers,et al.  Mouse models of diabetic nephropathy , 2011, Current opinion in nephrology and hypertension.

[2]  O. Smithies,et al.  The kallikrein-kinin system in health and in diseases of the kidney. , 2009, Kidney international.

[3]  M. Rastaldi,et al.  Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy , 2009, Diabetes.

[4]  W. Almawi,et al.  Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. , 2008, Journal of diabetes and its complications.

[5]  I. Tack,et al.  Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. , 2008, American journal of physiology. Renal physiology.

[6]  N. Musi,et al.  Diabetic eNOS knockout mice develop distinct macro- and microvascular complications , 2008, Laboratory Investigation.

[7]  C. Esmon,et al.  Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis , 2007, Nature Medicine.

[8]  E. Bottinger,et al.  Decorin deficiency enhances progressive nephropathy in diabetic mice. , 2007, The American journal of pathology.

[9]  GH Tesch.  ROLE OF MACROPHAGES IN COMPLICATIONS OF TYPE 2 DIABETES , 2007, Clinical and experimental pharmacology & physiology.

[10]  I. Tack,et al.  ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats. , 2007, American journal of physiology. Renal physiology.

[11]  S. Lipsitz,et al.  Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy. , 2007, American journal of physiology. Renal physiology.

[12]  M. Caramori,et al.  Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy , 2007, Diabetes.

[13]  R. Elston,et al.  Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations , 2007, Diabetes.

[14]  M. Gannon,et al.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. , 2007, The American journal of pathology.

[15]  T. Coffman,et al.  Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link? , 2007, Journal of the American Society of Nephrology : JASN.

[16]  B. Croker,et al.  Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.

[17]  G. Boysen,et al.  Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. , 2007, Kidney international.

[18]  A. Brewer,et al.  GATA factors in vertebrate heart development and disease , 2006, Expert Reviews in Molecular Medicine.

[19]  S. Shankland,et al.  The podocyte's response to injury: role in proteinuria and glomerulosclerosis. , 2006, Kidney international.

[20]  C. R. Bagnell,et al.  Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. , 2006, The Journal of clinical investigation.

[21]  F. Brosius,et al.  Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment , 2006, BMC nephrology.

[22]  C. Cunningham,et al.  Role for GLUT1 in diabetic glomerulosclerosis , 2006, Expert Reviews in Molecular Medicine.

[23]  Hengjun Chao,et al.  RNA repair for haemophilia A , 2006, Expert Reviews in Molecular Medicine.

[24]  L. Holzman,et al.  Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. , 2005, Journal of the American Society of Nephrology : JASN.

[25]  K. Eguchi,et al.  Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. , 2005, Diabetes.

[26]  A. Lundblad,et al.  Creatinine concentration in plasma from dog, rat, and mouse: a comparison of 3 different methods. , 2005, Veterinary clinical pathology.

[27]  Jianping Jin,et al.  Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. , 2005, Diabetes.

[28]  R. Iozzo,et al.  Decorin, a Novel Player in the Insulin-like Growth Factor System* , 2005, Journal of Biological Chemistry.

[29]  S. Marshall.  The Podocyte: A Major Player in the Development of Diabetic Nephropathy? , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[30]  E. Ritz,et al.  Nephron number and renal risk in hypertension and diabetes. , 2005, Journal of the American Society of Nephrology : JASN.

[31]  Hyung-Suk Kim,et al.  Lifelong genetic minipumps. , 2005, Physiological genomics.

[32]  N. Metreveli,et al.  Development of late-stage diabetic nephropathy in OVE26 diabetic mice. , 2004, Diabetes.

[33]  O. Smithies,et al.  Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Li,et al.  Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors. , 2004, Diabetes.

[35]  Merlin C. Thomas,et al.  Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. , 2004, Journal of the American Society of Nephrology : JASN.

[36]  M. Reitman,et al.  Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. , 2004, Endocrinology.

[37]  R. Atkins,et al.  Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy , 2004, Diabetologia.

[38]  R. Star,et al.  A simplified method for HPLC determination of creatinine in mouse serum. , 2004, American journal of physiology. Renal physiology.

[39]  H. Pan,et al.  Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity. , 2004, Metabolism: clinical and experimental.

[40]  R. McCarter,et al.  Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. , 2004, Diabetes care.

[41]  E. Bottinger,et al.  Utility of endogenous creatinine clearance as a measure of renal function in mice. , 2004, Kidney international.

[42]  M. Cooper,et al.  Use of genetic mouse models in the study of diabetic nephropathy , 2004, Current diabetes reports.

[43]  G. Churchill,et al.  Genetic analysis of blood pressure in C3H/HeJ and SWR/J mice. , 2004, Physiological genomics.

[44]  M. Cooper,et al.  Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. , 2004, The American journal of pathology.

[45]  J. Peters,et al.  Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. , 2004, Metabolism: clinical and experimental.

[46]  Min Zhao,et al.  Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. , 2004, American journal of physiology. Renal physiology.

[47]  D. Liang,et al.  Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. , 2004, Diabetes.

[48]  E. Leiter,et al.  Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. , 2004, Diabetes.

[49]  C. Alpers,et al.  Original Report: Laboratory Investigation Hyperglycemia and Hyperlipidemia Act Synergistically to Induce Renal Disease in Ldl Receptor-deficient Balb Mice , 2022 .

[50]  M. Elisaf,et al.  Apolipoprotein E and renal disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  T. Kern,et al.  Adipose differentiation-related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney. , 2004, American journal of physiology. Renal physiology.

[52]  T. Lyons,et al.  Nephropathy in a Hypercholesterolemic Mouse Model with Streptozotocin-Induced Diabetes , 2003, Kidney and Blood Pressure Research.

[53]  F. Ziyadeh,et al.  Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. , 2003, Seminars in nephrology.

[54]  Y. Tomino,et al.  Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice. , 2003, Journal of nephrology.

[55]  B. Klanke,et al.  Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[56]  G. Striker,et al.  Glucose induces clonal selection and reversible dinucleotide repeat expansion in mesangial cells isolated from glomerulosclerosis-prone mice. , 2003, Diabetes.

[57]  D. Lackland,et al.  Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. , 2003, Kidney international.

[58]  J. She,et al.  Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. , 2003, Diabetes.

[59]  S. Araki,et al.  APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. , 2003, Diabetes care.

[60]  Charles Maynard,et al.  Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. , 2003, Diabetes care.

[61]  C. Mogensen,et al.  Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes * , 2003, Journal of internal medicine.

[62]  Li-jun Ma,et al.  Model of robust induction of glomerulosclerosis in mice: importance of genetic background. , 2003, Kidney international.

[63]  S. Iyengar,et al.  Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[64]  A. Roberts,et al.  Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. , 2003, Biochemical and biophysical research communications.

[65]  Kumar Sharma,et al.  Diabetic kidney disease in the db/db mouse. , 2003, American journal of physiology. Renal physiology.

[66]  Hyung-Suk Kim,et al.  Minireview: computer simulations of blood pressure regulation by the renin-angiotensin system. , 2003, Endocrinology.

[67]  J. Naggert,et al.  New leptin receptor mutations in mice: Lepr(db-rtnd), Lepr(db-dmpg) and Lepr(db-rlpy). , 2003, The Journal of nutrition.

[68]  V. D’Agati,et al.  Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[69]  Jessica A Risan,et al.  Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[70]  Mark A. Sabol,et al.  Differential mechanisms and development of leptin resistance in A/J versus C57BL/6J mice during diet-induced obesity. , 2003, Endocrinology.

[71]  V. D’Agati,et al.  RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. , 2003, The American journal of pathology.

[72]  N. Belyaev,et al.  Nitric oxide synthase gene polymorphisms and diabetic nephropathy , 2003, Diabetologia.

[73]  K. Taniguchi,et al.  Renal Lesions in Spontaneous Insulin-dependent Diabetes Mellitus in the Nonobese Diabetic Mouse: Acute Phase of Diabetes , 2003, Veterinary pathology.

[74]  Hisayo Fujita,et al.  The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[75]  M. Haneda,et al.  Progression of diabetic nephropathy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[76]  W. Beischer,et al.  Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[77]  E. Schleicher,et al.  Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. , 2003, Diabetes.

[78]  Y. Tomino,et al.  Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. , 2002, Diabetes research and clinical practice.

[79]  A. Komatsuda,et al.  Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse. , 2002, The Tohoku journal of experimental medicine.

[80]  P. Doevendans,et al.  The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide , 2002, Journal of hypertension.

[81]  K. Tokunaga,et al.  Association of eNOS Glu298Asp Polymorphism With End-Stage Renal Disease , 2002, Hypertension.

[82]  R. Ferrell,et al.  Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. , 2002, Kidney international.

[83]  P. Yu,et al.  Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet , 2002, Diabetologia.

[84]  M. Matsuda,et al.  Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[85]  Tomoya Yamashita,et al.  Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. , 2002, The Journal of clinical investigation.

[86]  Shan Lin,et al.  Allele A in Intron 4 of ecNOS Gene Will Not Increase the Risk of Diabetic Nephropathy in Type 2 Diabetes of Chinese Population , 2002, Nephron.

[87]  H. Rabb,et al.  Utility and limitations of serum creatinine as a measure of renal function in experimental renal ischemia-reperfusion injury. , 2002, Transplantation.

[88]  P. Fisher,et al.  Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB-Leprdb) and obese (DBA-Lepob) mice , 2002, Diabetologia.

[89]  C. Mathews,et al.  New mouse model to study islet transplantation in insulin-dependent diabetes mellitus , 2002, Transplantation.

[90]  E. Leiter,et al.  Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. , 2002, Diabetes.

[91]  D. Ron.  Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. , 2002, The Journal of clinical investigation.

[92]  B. Thorens,et al.  Differential Sensitivity of GLUT1- and GLUT2-Expressing β Cells to Streptozotocin , 2001 .

[93]  R. Atkins,et al.  Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). , 2001, The Journal of clinical investigation.

[94]  C. Shearman,et al.  Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice. , 2001, Metabolism: clinical and experimental.

[95]  G. Striker,et al.  Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. , 2001, The Journal of clinical investigation.

[96]  Jiqiu Chen,et al.  Hypertension Does Not Account for the Accelerated Atherosclerosis and Development of Aneurysms in Male Apolipoprotein E/Endothelial Nitric Oxide Synthase Double Knockout Mice , 2001, Circulation.

[97]  A. Koizumi,et al.  Increased Expression of Glutathione S- Transferase in Renal Proximal Tubules in the Early Stages of Diabetes: A Study of Type-2 Diabetes in the Akita Mouse Model , 2001, Nephron Experimental Nephrology.

[98]  W. Lü,et al.  [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy]. , 2001, Zhonghua nei ke za zhi.

[99]  M. Marre,et al.  Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Paul L Huang,et al.  Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice , 2001, Circulation.

[101]  N. Shcherbak.  Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study , 2001, BMC Medical Genetics.

[102]  S. Takasawa,et al.  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. , 2001, The Journal of clinical investigation.

[103]  B. Isermann,et al.  Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. , 2001, Diabetes research and clinical practice.

[104]  M. Isono,et al.  Increased Glomerular and Tubular Expression of Transforming Growth Factor-β1, Its Type II Receptor, and Activation of the Smad Signaling Pathway in the db/db Mouse , 2001 .

[105]  Paul Scherz,et al.  Defining brain wiring patterns and mechanisms through gene trapping in mice , 2001, Nature.

[106]  R. Davisson,et al.  Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. , 2001, Physiological genomics.

[107]  H. Gröne,et al.  Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[108]  N. Yorioka,et al.  Endothelial Nitric Oxide Synthase Intron 4 Polymorphism Influences the Progression of Renal Disease , 2001, Nephron.

[109]  F. Sugiyama,et al.  Mouse models of blood pressure regulation and hypertension , 2001, Current hypertension reports.

[110]  M. Nawano,et al.  Improved diabetic syndrome in C57BL/KsJ‐db/db mice by oral administration of the Na+‐glucose cotransporter inhibitor T‐1095 , 2001, British journal of pharmacology.

[111]  W. Noonan,et al.  Renal Function and Glucose Transport in Male and Female Mice with Diet-Induced Type II Diabetes Mellitus (44568) , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[112]  R. Krediet,et al.  The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis. , 2000, Journal of internal medicine.

[113]  D. Moczulski,et al.  APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. , 2000, Diabetes.

[114]  S. Hadjadj,et al.  Lack of relationship in long‐term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein ε, lipoprotein lipase and cholesteryl ester transfer protein , 2000 .

[115]  C. Babinet.  Transgenic mice: an irreplaceable tool for the study of mammalian development and biology. , 2000, Journal of the American Society of Nephrology : JASN.

[116]  S. Rich,et al.  Genetic analysis of nitric oxide and endothelin in end-stage renal disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[117]  Alan W. Stitt,et al.  Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. , 2000, Kidney international.

[118]  D. Moczulski,et al.  Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. , 2000, Kidney international.

[119]  T. Inomata,et al.  Microvasculature of hydronephrotic kidneys in KK-A(Y) mice. , 2000, The Journal of veterinary medical science.

[120]  N. Wahab,et al.  The decorin high glucose response element and mechanism of its activation in human mesangial cells. , 2000, Journal of the American Society of Nephrology : JASN.

[121]  V. D’Agati,et al.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. , 2000, Journal of the American Society of Nephrology : JASN.

[122]  M. Mauer,et al.  The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? , 2000, Diabetes.

[123]  Klaus Schughart,et al.  Genome-wide, large-scale production of mutant mice by ENU mutagenesis , 2000, Nature Genetics.

[124]  K. Sharma,et al.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[125]  H. Narita,et al.  Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. , 2000, European journal of pharmacology.

[126]  K. Dohi,et al.  Serum IgA levels in patients with diabetic nephropathy and IgA nephropathy superimposed on diabetes mellitus. , 2000, Diabetes research and clinical practice.

[127]  H. Parving,et al.  Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[128]  E. Kilpatrick,et al.  Glycated haemoglobin in the year 2000 , 2000, Journal of clinical pathology.

[129]  S. Neugebauer,et al.  Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. , 2000, Diabetes.

[130]  G. King,et al.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[131]  J. Knowles,et al.  Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. , 2000, The Journal of clinical investigation.

[132]  C. Chung,et al.  Immunoglobulin A nephropathy in patients with non-insulin dependent diabetes mellitus. , 1999, Journal of Korean medical science.

[133]  J. Sanes,et al.  Regulation of renal laminin in mice with type II diabetes. , 1999, Journal of the American Society of Nephrology : JASN.

[134]  H. Parving,et al.  Progression of diabetic nephropathy in normotensive type 1 diabetic patients. , 1999, Kidney international. Supplement.

[135]  Jae Hyun Kim,et al.  Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J. , 1999, Journal of lipid research.

[136]  K. Nakao,et al.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.

[137]  KazuwaNakao,et al.  T−786→C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm , 1999 .

[138]  R. Mahley,et al.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.

[139]  M. Atkinson,et al.  The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.

[140]  R. Krediet,et al.  Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion: relevance of the creatinine assay. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[141]  A. Krolewski.  Genetics of diabetic nephropathy: evidence for major and minor gene effects. , 1999, Kidney international.

[142]  K. Sekikawa,et al.  Quantitative trait loci that regulate plasma lipid concentration in hereditary obese KK and KK-Ay mice. , 1999, Biochimica et biophysica acta.

[143]  G. Striker,et al.  Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. , 1999, The American journal of pathology.

[144]  T. Inomata,et al.  Obstructive uropathy and hydronephrosis in male KK-Ay mice: a report of cases. , 1999, The Journal of veterinary medical science.

[145]  K. Imamura,et al.  Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice. , 1998, European journal of endocrinology.

[146]  T. Latifi,et al.  Diet-induced Diabetes Activates an Osteogenic Gene Regulatory Program in the Aortas of Low Density Lipoprotein Receptor-deficient Mice* , 1998, The Journal of Biological Chemistry.

[147]  H. Hoeger,et al.  Aromatic hydroxylation in animal models of diabetes mellitus , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[148]  F. Ziyadeh,et al.  Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. , 1998, American journal of physiology. Renal physiology.

[149]  T. Saibara,et al.  Abnormally Decreased HbA1c Can Be Assessed With Erythrocyte Creatine in Patients With a Shortened Erythrocyte Age , 1998, Diabetes Care.

[150]  K. Nakao,et al.  A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese , 1998, Human Genetics.

[151]  D. Goldstein,et al.  What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. , 1998, Clinical chemistry.

[152]  K. Imamura,et al.  Genetics of obesity in KK mouse and effects of Ay allele on quantitative regulation , 1998, Mammalian Genome.

[153]  H. Itoh,et al.  Endothelial nitric oxide synthase gene is positively associated with essential hypertension. , 1998, Hypertension.

[154]  Y. Kawaguchi,et al.  High Accumulation of Endothelial Nitric Oxide Synthase (ecNOS):A Gene Polymorphism in Patients with End-Stage Renal Disease , 1998, Nephron.

[155]  M. Cameron,et al.  Failure in immune regulation begets IDDM in NOD mice. , 1998, Diabetes/metabolism reviews.

[156]  E. Werle,et al.  Apolipoprotein E Polymorphism and Renal Function in German Type 1 and Type 2 Diabetic Patients , 1998, Diabetes Care.

[157]  R. Hanson,et al.  Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. , 1998, Diabetes.

[158]  Y. Kawaguchi,et al.  Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. , 1998, Biochemical and biophysical research communications.

[159]  J. Todd,et al.  Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM , 1998, Diabetes.

[160]  B. Keevil,et al.  Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring , 1998, Diabetes Care.

[161]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[162]  J. Wilkinson,et al.  The role of the agouti gene in the yellow obese syndrome. , 1997, The Journal of nutrition.

[163]  J. Connor,et al.  Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. , 1997, American journal of human genetics.

[164]  V. Emilsson,et al.  Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice , 1997, FEBS letters.

[165]  R. Leibel.  And finally, genes for human obesity , 1997, Nature Genetics.

[166]  S. Freytag,et al.  D-Glucose Stimulates Mesangial Cell GLUT1 Expression and Basal and IGF-I–Sensitive Glucose Uptake in Rat Mesangial Cells: Implications for Diabetic Nephropathy , 1997, Diabetes.

[167]  R. Osterby,et al.  Decreasing glomerular filtration rate--an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents? , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[168]  S. Rich,et al.  Linkage of Genetic Markers on Human Chromosomes 20 and 12 to NIDDM in Caucasian Sib Pairs With a History of Diabetic Nephropathy , 1997, Diabetes.

[169]  Masato Yoshioka,et al.  A Novel Locus, Mody4, Distal to D7Mit189 on Chromosome 7 Determines Early-Onset NIDDM in Nonobese C57BL/6 (Akita) Mutant Mice , 1997, Diabetes.

[170]  K. Dan,et al.  Relation between stable glycated hemoglobin A1C and plasma glucose levels in diabetes-model mice. , 1997, Experimental animals.

[171]  B. Rosen,et al.  Rapid sequence analysis of gene trap integrations to generate a resource of insertional mutations in mice. , 1997, Genome research.

[172]  S. Brunnert.  Morphologic response of myocardium to freeze-thaw injury in mouse strains with dystrophic cardiac calcification. , 1997, Laboratory animal science.

[173]  T. Meyer,et al.  Podocyte loss and progressive glomerular injury in type II diabetes. , 1997, The Journal of clinical investigation.

[174]  T. Nakayama,et al.  Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese , 1997, Clinical genetics.

[175]  L. Klevay,et al.  Ultrastructural and functional analyses of nephropathy in calmodulin‐induced diabetic transgenic mice , 1997, The Anatomical record.

[176]  I. Weber,et al.  Model Structure of Decorin and Implications for Collagen Fibrillogenesis* , 1996, The Journal of Biological Chemistry.

[177]  A. Krolewski,et al.  Apolipoprotein E genotypes and risk of diabetic nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.

[178]  J. Cohen,et al.  Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. , 1996, Experimental nephrology.

[179]  L. Tartaglia,et al.  Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) Receptor , 1996, Science.

[180]  J. Friedman,et al.  Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.

[181]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[182]  I. Makino,et al.  Increased frequency of apolipoprotein ε2 allele in non‐insulin dependent diabetic (NIDDM) patients with nephropathy , 1995 .

[183]  S. Freytag,et al.  Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. , 1995, The Journal of clinical investigation.

[184]  D. L. Wilson,et al.  Hyper- and hypo-responsiveness to dietary fat and cholesterol among inbred mice: searching for level and variability genes. , 1995, Journal of lipid research.

[185]  J. Geisler,et al.  Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[186]  A. Krolewski,et al.  Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[187]  J. Charles Jennette,et al.  Male–female differences in fertility and blood pressure in ACE-deficient mice , 1995, Nature.

[188]  N. Copeland,et al.  Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. , 1995, Genetics.

[189]  J. Rodin,et al.  Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. , 1995, Metabolism: clinical and experimental.

[190]  J. Naggert,et al.  Genomic analysis of the C57BL/Ks mouse strain , 1995, Mammalian Genome.

[191]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[192]  K. Sharma,et al.  Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. , 1994, The American journal of physiology.

[193]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[194]  O. Smithies,et al.  Altering mice by homologous recombination using embryonic stem cells. , 1994, The Journal of biological chemistry.

[195]  M. Steffes,et al.  Glomerular Structure in Nonproteinuric IDDM Patients With Various Levels of Albuminuria , 1994, Diabetes.

[196]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[197]  O. Pankewycz,et al.  Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. , 1994, Kidney international.

[198]  P. Schmezer,et al.  Tissue-specific induction of mutations by streptozotocin in vivo. , 1994, Mutation research.

[199]  A. Krolewski,et al.  Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene , 1994, Diabetes.

[200]  L. Stubbs,et al.  A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[201]  F. Cambien,et al.  Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications , 1994, Diabetes.

[202]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[203]  C. Peterson,et al.  Sex differences in glycated hemoglobin in diabetic and non-diabetic C57BL/6 mice. , 1993, Diabetes research and clinical practice.

[204]  W. Toyofuku,et al.  Atherosclerosis and plasma and liver lipids in nine inbred strains of mice , 1993, Lipids.

[205]  K. Doi,et al.  Glomerular lesions in unilateral nephrectomized and diabetic (UN-D) mice. , 1992, The Journal of veterinary medical science.

[206]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[207]  M. Steffes,et al.  Renal structure and function in insulin-dependent diabetes mellitus in man. , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[208]  A. Means,et al.  Elevated beta-cell calmodulin produces a unique insulin secretory defect in transgenic mice. , 1992, Endocrinology.

[209]  G. Striker,et al.  Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[210]  O. E. Michaelis,et al.  Animal models of spontaneous diabetic kidney disease , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[211]  A. Means,et al.  Calmodulin-induced early-onset diabetes in transgenic mice , 1989, Cell.

[212]  T. Onodera,et al.  Rapid development of renal lesions in diabetic DBA mice infected with the D-variant of encephalomyocarditis virus (EMC-D). , 1989, British journal of experimental pathology.

[213]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[214]  R. Bilous,et al.  Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. , 1989, The New England journal of medicine.

[215]  D. Coleman,et al.  The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. , 1989, Endocrinology.

[216]  M. Feinglos,et al.  Diet-Induced Type II Diabetes in C57BL/6J Mice , 1988, Diabetes.

[217]  M. Permutt,et al.  Genetic Analysis of Glucose Tolerance in Inbred Mouse Strains: Evidence for Polygenic Control , 1988, Diabetes.

[218]  T. Onodera,et al.  Histopathology of BALB/c mice infected with the D variant of encephalomyocarditis virus. , 1988, British journal of experimental pathology.

[219]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[220]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[221]  E. Schenk,et al.  Increased Plasma IgA, sIgA, and C3- and IgA-Containing Immune Complexes With Renal Glomerular Deposits in Diabetic Rats , 1988, Diabetes.

[222]  B. Paigen,et al.  Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice , 1987, Biochemical Genetics.

[223]  D. Coleman,et al.  The non-obese diabetic (NOD) mouse. , 1987, The American journal of pathology.

[224]  H. Kolb,et al.  Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. , 1987, Diabetes/metabolism reviews.

[225]  M. Denaro,et al.  Expression of six mouse major urinary protein genes in the mammary, parotid, sublingual, submaxillary, and lachrymal glands and in the liver , 1987, Molecular and cellular biology.

[226]  A. Farr,et al.  Expression of Ia antigens by murine kidney epithelium after exposure to streptozotocin. , 1987, The American journal of pathology.

[227]  G. Utermann,et al.  Apolipoprotein E polymorphism in health and disease. , 1987, American heart journal.

[228]  S. Genuth,et al.  Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group , 1987, Diabetes Care.

[229]  K. Doi,et al.  Histopathology of streptozotocin-induced diabetic DBA/2N and CD-1 mice , 1986, Laboratory animals.

[230]  E. Ritz,et al.  Natural History of Nephropathy in Type I Diabetes: Relationship to Metabolic Control and Blood Pressure , 1985, Hypertension.

[231]  S. Gerard,et al.  Characterization of creatinine error in ketotic patients. A prospective comparison of alkaline picrate methods with an enzymatic method. , 1985, American journal of clinical pathology.

[232]  M. Steffes,et al.  Structural-functional relationships in diabetic nephropathy. , 1984, The Journal of clinical investigation.

[233]  J. Wolf,et al.  The Influence of Genetic Background on the Susceptibility of Inbred Mice to Streptozotocin-induced Diabetes , 1984, Diabetes.

[234]  A. V. Williams,et al.  Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. , 1982, Human pathology.

[235]  R. Bressler,et al.  Metabolic Control of Prevention of Nephropathy by 2-Tetradecylglycidate in the Diabetic Mouse (db/db) , 1982, Diabetes.

[236]  H. Hackbarth,et al.  Genetic analysis of renal function in mice. 2. Strain differences in clearances of sodium, potassium, osmolar and free water, and their correlations with body and kidney weight , 1982, Laboratory animals.

[237]  K. Hummel,et al.  The Influence of Genetic Background on the Expression of Mutations at the Diabetes Locus in the Mouse: III. Effect of H-2 Haplotype and Sex , 1981, Diabetes.

[238]  E. Leiter.  The Influence of Genetic Background on the Expression of Mutations at the Diabetes Locus in the Mouse: IV. Male Lethal Syndrome in CBA/Lt Mice , 1981, Diabetes.

[239]  R. Bressler,et al.  Prevention of Diabetic Nephropathy by Diet Control in the db/db Mouse , 1981, Diabetes.

[240]  A. Steinberg,et al.  Diabetes is Associated with Autoimmunity in the New Zealand Obese (NZO) Mouse , 1980, Diabetes.

[241]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[242]  F. Giacomelli,et al.  Primary myocardial disease in the diabetic mouse. An ultrastructural study. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[243]  A. Reddi,et al.  Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis. , 1978, Experimental and molecular pathology.

[244]  K. Gärtner.  Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (C57BL/6Jdb/db and C57BL/KsJdb/db) , 1978, Diabetologia.

[245]  R. Shapiro,et al.  Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. , 1978, The Journal of biological chemistry.

[246]  A. Rossini,et al.  Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[247]  A. Rossini,et al.  Genetic Influence of the Streptozotocin-induced Insulitis and Hyperglycemia , 1977, Diabetes.

[248]  A. Reddi,et al.  Diabetic microangiopathy in KK mice. II. Suppression of Glomerulosclerosis by pyridinolcarbamate. , 1977, Experimental and molecular pathology.

[249]  A. Rossini,et al.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. , 1976, Science.

[250]  A. Cerami,et al.  Increased Hemoglobin AIc in Diabetic Mice , 1976, Diabetes.

[251]  D. Coleman,et al.  Symposium IV: Diabetic syndrome in animals. Influence of genetic background on the expression of mutations at the diabetes locus in the mouse. II. Studies on background modifiers. , 1975, Israel journal of medical sciences.

[252]  W. Chick,et al.  Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. , 1972, The American journal of pathology.

[253]  M. Potter,et al.  Major Urinary Protein Complex of Normal Mice: Origin , 1965, Science.

[254]  Merton S. Honeyman,et al.  Biology of the Laboratory Mouse , 1957, The Yale Journal of Biology and Medicine.

[255]  N. Gretz,et al.  Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. , 2007, Kidney international.

[256]  B. Wajchenberg,et al.  The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course , 2007, Acta diabetologia latina.

[257]  R. Harris,et al.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. , 2006, Journal of the American Society of Nephrology : JASN.

[258]  N. Futrakul,et al.  Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. , 2006, Clinical hemorheology and microcirculation.

[259]  T. Meyer,et al.  Impact of genetic background on nephropathy in diabetic mice. , 2006, American journal of physiology. Renal physiology.

[260]  M. Schiffer,et al.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. , 2006, Diabetes.

[261]  R. Elston,et al.  The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. , 2005, Journal of diabetes and its complications.

[262]  藤本 昌紀.  Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy , 2005 .

[263]  W. Frankel,et al.  The AXB and BXA set of recombinant inbred mouse strains , 2004, Mammalian Genome.

[264]  L. Scarpellino,et al.  Nonobese diabetic and nonobese nondiabetic mice have unique MHC class II haplotypes , 2004, Immunogenetics.

[265]  R. Atkins,et al.  Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. , 2004, Kidney international.

[266]  D. Coleman,et al.  Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits , 2004, Immunogenetics.

[267]  Mark E Molitch,et al.  Nephropathy in diabetes. , 2004, Diabetes care.

[268]  H. Kawachi,et al.  Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. , 2003, Journal of the American Society of Nephrology : JASN.

[269]  USRDS: the United States Renal Data System. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[270]  H. Makino,et al.  Role of macrophages in the pathogenesis of diabetic nephropathy. , 2001, Contributions to nephrology.

[271]  B. Thorens,et al.  Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. , 2001, Biochemical and biophysical research communications.

[272]  E. Ritz,et al.  A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[273]  A. Mansouri.  Determination of gene function by homologous recombination using embryonic stem cells and knockout mice. , 2001, Methods in molecular biology.

[274]  Janan T. Eppig,et al.  Genealogies of mouse inbred strains , 2000, Nature Genetics.

[275]  H. Parving,et al.  Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. , 2000, Diabetes care.

[276]  S. Hadjadj,et al.  Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Rés , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[277]  塚田 敏彦.  Evidence of Association of the ecNOS Gene Polymorphism with Plasma NO Metabolite Levels in Humans , 2000 .

[278]  E. Gruenstein,et al.  A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. , 1999, American journal of physiology. Renal physiology.

[279]  Danhong Lu,et al.  A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. , 1999, The Journal of clinical investigation.

[280]  E. Gruenstein,et al.  A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. , 1999, The American journal of physiology.

[281]  J. Bosson,et al.  ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM? , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[282]  D. L. Wilson,et al.  C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. , 1998, Atherosclerosis.

[283]  G. Striker,et al.  Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. , 1998, Kidney international.

[284]  K. Nakao,et al.  Yukio Hypertension Endothelial Nitric Oxide Synthase Gene Is Positively Associated With Essential , 1998 .

[285]  K. Doi,et al.  Involvement of macrophages in the development of encephalomyocarditis (EMC) virus-induced diabetes in mice. , 1996, Experimental animals.

[286]  F. Brosius,et al.  Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[287]  K. Doi,et al.  Histopathology of subacute renal lesions in mice induced by streptozotocin. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[288]  M. Eto,et al.  Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. , 1995, Clinical genetics.

[289]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[290]  F. Cambien,et al.  Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. , 1994, Diabetes.

[291]  M. Feinglos,et al.  Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. , 1993, The American journal of physiology.

[292]  Rudolfs K. Zalups.  The Os/+ mouse: a genetic animal model of reduced renal mass. , 1993, The American journal of physiology.

[293]  N. Hotta,et al.  Unique glomerular lesion with spontaneous lipid deposition in glomerular capillary lumina in the NON strain of mice. , 1991, Nephron.

[294]  K. Shichinohe,et al.  Kidney complications in EMC virus-induced diabetes in conventional DBA/2 male mice. , 1990, Jikken dobutsu. Experimental animals.

[295]  E. Leiter,et al.  Streptozotocin interactions with pancreatic beta cells and the induction of insulin-dependent diabetes. , 1990, Current topics in microbiology and immunology.

[296]  N. Altman,et al.  Dystrophic cardiac calcinosis in mice: abnormal myocardial response to freeze-thaw injury. , 1990, Laboratory animal science.

[297]  C. Mogensen.  The effect of blood pressure intervention on renal function in insulin-dependent diabetes. , 1989, Diabete & metabolisme.

[298]  Mogensen Ce.  The effect of blood pressure intervention on renal function in insulin-dependent diabetes. , 1989 .

[299]  A. Reddi,et al.  Kidney disease in KK mice: structural, biochemical and functional relationships. , 1988, Advances in experimental medicine and biology.

[300]  T. Matsui,et al.  Increase in basal pulse rate and blood pressure by the diabetic state in KK-CAy mice, alloxan-mice and streptozotocin-mice. , 1988, Japanese journal of pharmacology.

[301]  K. Jung,et al.  Specific Creatinine Determination in Laboratory Animals Using the New Enzymatic Test Kit “Creatinine-PAP” , 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[302]  T. Hanafusa,et al.  Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic NOD mouse , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[303]  R. Gray,et al.  Picric acid methods greatly overestimate serum creatinine in mice: more accurate results with high-performance liquid chromatography. , 1985, Analytical biochemistry.

[304]  E. Leiter.  Differential susceptibility of BALB/c sublines to diabetes induction by multi-dose streptozotocin treatment. , 1985, Current topics in microbiology and immunology.

[305]  E. Fujii,et al.  Changes in glycosylated hemoglobin in short- and semi long-term streptozotocin-diabetic mice and rats. , 1984, Japanese journal of pharmacology.

[306]  E. Leiter.  Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[307]  R. G. Simmonds,et al.  The relationship between hyperglycaemia and renal immune complex deposition in mice with inherited diabetes. , 1981, Clinical and experimental immunology.

[308]  H. Hackbarth,et al.  [Determination of the mouse glomerular filtration rate by total 51Cr-EDTA plasma slope clearance depending on age and sex]. , 1979, Zeitschrift fur Versuchstierkunde.

[309]  R. Camerini‐Davalos,et al.  Glomerulosclerosis in a strain of genetically diabetic mice. , 1968, Diabetes.

[310]  Gordon Ee.  K+ transport and glycolysis. , 1968 .

[311]  C. Lewis,et al.  Streptozotocin, a new antibiotic. In vitro and in vivo evaluation. , 1959, Antibiotics annual.